Insider · CIK 0001583903

DArecca James

Reports to the SEC for 5 companies · TARRYTOWN, NY

sec.gov

Transactions

Companies

Filings

CIK

0001583903

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-04	PBHPrestige Consumer Healthcare Inc.A Award	Director	AAward	+2,981 sh	—	—	9,572
2026-05-15	HAEHAEMONETICS CORPF Tax Payment	EVP, Chief Financial Officer	FTax Payment	−2,505 sh	$56.29	−$141K	25,132
2026-05-15	HAEHAEMONETICS CORPA Award	EVP, Chief Financial Officer	AAward	+29.3K sh	—	—	54,444
2026-05-01	HAEHAEMONETICS CORPF Tax Payment	EVP, Chief Financial Officer	FTax Payment	−655 sh	$59.26	−$38.8K	27,637
2025-08-05	PBHPrestige Consumer Healthcare Inc.A Award	Director	AAward	+2,094 sh	—	—	6,591
2025-05-30	HAEHAEMONETICS CORPA Award	EVP, Chief Financial Officer	AAward	+12.2K sh	—	—	34,156
2025-05-30	HAEHAEMONETICS CORPF Tax Payment	EVP, Chief Financial Officer	FTax Payment	−5,864 sh	$69.38	−$407K	28,292
2025-05-16	HAEHAEMONETICS CORP · Non-qualified Stock Option (Right to Buy)A Award	EVP, Chief Financial Officer	AAward	+15.4K sh	—	—	15,396
2025-05-16	HAEHAEMONETICS CORPA Award	EVP, Chief Financial Officer	AAward	+7,111 sh	—	—	21,935
2025-05-16	HAEHAEMONETICS CORPF Tax Payment	EVP, Chief Financial Officer	FTax Payment	−1,246 sh	$70.31	−$87.6K	14,824
2025-05-15	HAEHAEMONETICS CORPF Tax Payment	EVP, Chief Financial Officer	FTax Payment	−622 sh	$69.38	−$43.2K	16,070
2025-05-02	HAEHAEMONETICS CORPF Tax Payment	EVP, Chief Financial Officer	FTax Payment	−654 sh	$63.85	−$41.8K	16,692
2024-08-06	PBHPrestige Consumer Healthcare Inc.A Award	Director	AAward	+2,202 sh	—	—	4,497
2024-05-17	HAEHAEMONETICS CORP · Non-qualified Stock Option (Right to Buy)A Award	EVP, Chief Financial Officer	AAward	+9,756 sh	—	—	9,756
2024-05-17	HAEHAEMONETICS CORPA Award	EVP, Chief Financial Officer	AAward	+4,439 sh	—	—	17,346
2024-05-16	HAEHAEMONETICS CORPF Tax Payment	EVP, Chief Financial Officer	FTax Payment	−351 sh	$94.80	−$33.3K	12,907
2024-05-15	HAEHAEMONETICS CORPF Tax Payment	EVP, Chief Financial Officer	FTax Payment	−412 sh	$96.49	−$39.8K	13,258
2024-05-02	HAEHAEMONETICS CORPF Tax Payment	EVP, Chief Financial Officer	FTax Payment	−432 sh	$93.33	−$40.3K	13,670
2023-08-01	PBHPrestige Consumer Healthcare Inc.A Award	Director	AAward	+2,295 sh	—	—	2,295
2023-05-16	HAEHAEMONETICS CORPF Tax Payment	EVP, Chief Financial Officer	FTax Payment	−349 sh	$89.21	−$31.1K	14,102
2023-05-15	HAEHAEMONETICS CORPA Award	EVP, Chief Financial Officer	AAward	+4,205 sh	—	—	14,451
2023-05-15	HAEHAEMONETICS CORP · Non-qualified Stock Option (Right to Buy)A Award	EVP, Chief Financial Officer	AAward	+9,502 sh	—	—	9,502
2023-05-02	HAEHAEMONETICS CORPF Tax Payment	EVP, Chief Financial Officer	FTax Payment	−430 sh	$81.66	−$35.1K	10,246
2022-05-16	HAEHAEMONETICS CORPA Award	EVP, Chief Financial Officer	AAward	+4,774 sh	—	—	10,676
2022-05-16	HAEHAEMONETICS CORP · Non-qualified Stock Option (Right to Buy)A Award	EVP, Chief Financial Officer	AAward	+11.2K sh	—	—	11,163
2022-05-02	HAEHAEMONETICS CORP · Non-qualified Stock Option (Right to Buy)A Award	EVP, Chief Financial Officer	AAward	+13.8K sh	—	—	13,828
2022-05-02	HAEHAEMONETICS CORPA Award	EVP, Chief Financial Officer	AAward	+5,902 sh	—	—	5,902
2021-08-12	TXMDTherapeuticsMD, Inc.S Sale	Chief Financial Officer	SSale	−93.3K sh	$0.87	−$81.2K	123,830
2021-08-10	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+217K sh	—	—	217,167
2021-08-10	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−217K sh	—	—	434,333
2021-07-01	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+173K sh	—	—	173,333
2021-07-01	TXMDTherapeuticsMD, Inc. · Performance Stock UnitsA Award	Chief Financial Officer	AAward	+347K sh	—	—	346,667
2020-06-18	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+652K sh	—	—	651,500
2020-06-18	TXMDTherapeuticsMD, Inc. · Performance Stock UnitsA Award	Chief Financial Officer	AAward	+152K sh	—	—	151,500
2020-06-18	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+652K sh	—	—	651,500
2020-06-18	TXMDTherapeuticsMD, Inc. · Performance Stock UnitsA Award	Chief Financial Officer	AAward	+152K sh	—	—	151,500
2020-05-08	Allergan plcStock OptionsD Disposition to Issuer	SVP Chief Accounting Officer	DDisposition to Issuer	−1,169 sh	—	—	0
2020-05-08	Allergan plcD Disposition to Issuer	SVP Chief Accounting Officer	DDisposition to Issuer	−3,511 sh	—	—	0
2020-05-08	Allergan plcD Disposition to Issuer	SVP Chief Accounting Officer	DDisposition to Issuer	−6,324 sh	—	—	0
2020-05-08	Allergan plcPerformance Stock UnitsD Disposition to Issuer	SVP Chief Accounting Officer	DDisposition to Issuer	−3,534 sh	—	—	0
2020-05-08	Allergan plcStock OptionsD Disposition to Issuer	SVP Chief Accounting Officer	DDisposition to Issuer	−4,957 sh	—	—	0
2020-03-06	Allergan plcF Tax Payment	SVP Chief Accounting Officer	FTax Payment	−718 sh	$191.95	−$138K	9,834
2020-03-02	Allergan plcA Award	SVP Chief Accounting Officer	AAward	+3,611 sh	$193.84	+$700K	10,552
2019-12-31	Allergan plcF Tax Payment	SVP Chief Accounting Officer	FTax Payment	−92 sh	$191.17	−$17.6K	6,941
2019-03-08	Allergan plcF Tax Payment	SVP Chief Accounting Officer	FTax Payment	−113 sh	$145.06	−$16.4K	7,033
2019-03-07	Allergan plcF Tax Payment	SVP Chief Accounting Officer	FTax Payment	−359 sh	$143.00	−$51.3K	7,146
2019-03-06	Allergan plcA Award	SVP Chief Accounting Officer	AAward	+2,036 sh	$137.51	+$280K	7,505
2019-03-04	Allergan plcF Tax Payment	SVP Chief Accounting Officer	FTax Payment	−114 sh	$139.12	−$15.9K	5,469
2018-12-31	Allergan plcF Tax Payment	SVP Chief Accounting Officer	FTax Payment	−147 sh	$133.66	−$19.6K	5,453
2018-03-08	Allergan plcF Tax Payment	SVP Chief Accounting Officer	FTax Payment	−79 sh	$153.50	−$12.1K	5,600

Recent filings

Accepted (ET)
Aug 54
DArecca James0001104659-26-091082
SEC(opens sec.gov)
May 194
DArecca James0000313143-26-000046
SEC(opens sec.gov)
May 54
DArecca James0000313143-26-000026
SEC(opens sec.gov)
Aug 64
DArecca James0001104659-25-074702
SEC(opens sec.gov)
Jun 34
DArecca James0001127602-25-016517
SEC(opens sec.gov)
May 204
DArecca James0001127602-25-015054
SEC(opens sec.gov)
May 194
DArecca James0001127602-25-014944
SEC(opens sec.gov)
May 54
DArecca James0001127602-25-013343
SEC(opens sec.gov)
Aug 74
DArecca James0001104659-24-086748
SEC(opens sec.gov)
May 214
DArecca James0001127602-24-016162
SEC(opens sec.gov)
May 174
DArecca James0001127602-24-015864
SEC(opens sec.gov)
May 64
DArecca James0001127602-24-014274
SEC(opens sec.gov)
Aug 34
DArecca James0001104659-23-087189
SEC(opens sec.gov)
May 174
DArecca James0001127602-23-015929
SEC(opens sec.gov)

Companies

Address

660 WHITE PLAINS ROAD

TARRYTOWN, NY, 10591